Finzati - Logo
ABUS logo

Arbutus Biopharma Corp

ABUS • Biotechnology
$4.33
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$904.72M
Growth
-7.3%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 15.73Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:10 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.33
Change0.00%
Market Cap$904.72M
52W Range3.31 - 5.38
Beta0.60
Gross Margin97.42%
Oper. Margin-192.08%
Profit Margin-2.38%
Debt/Eq0.05
Current Ratio15.73
Quick Ratio15.73
Revenue 5Y-7.29%

Investment DNA

How strong this company looks for long-term investors

29
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 15.73Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$8.50
Mean
$8.50
Median
$8.50
High
$8.50

Company Overview

IPO: 7/26/2007
Industry: Biotechnology
P/B i: 12.04
Debt / Equity i: 0.05
Operating Margin: -192.08%
Net Margin: -237.88%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.05
Current Ratio: 15.73
Quick Ratio: 15.73
Status: Good

Insider Transactions

Recent executive and insider activity

Beardsley Robert A
Transaction: 06/08/2026
BUY
Change
+78,800
Price
$4.24
Filing
06/10/2026
Type
BUY
Sawhney Roger
Transaction: 06/08/2026
BUY
Change
+78,800
Price
$4.24
Filing
06/10/2026
Type
BUY
Androski Lindsay
Transaction: 02/02/2026
BUY
Change
+28,000
Price
Not reported
Filing
02/02/2026
Type
BUY